Vistagen Therapeutics (VTGN.MX) Q3 2026 Earnings

1JulConfirmed
Q1 2026
Next
-8.38
-7.54
-6.71
-5.87

Details

Expected EPS
-5.8683472881
Actual EPS
N/A
Surprise EPS
5.87
Surprise Percent
+100%

Description

Vistagen Therapeutics (VTGN.MX) will report earnings of for Q3 2026 on July 01, 2026.

0 Comments

Share your thoughts